- Home
- BKSY vs ATXS Comparison
BKSY vs ATXS Comparison
Compare BKSY & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- ATXS
- Stock Information
- Founded
- BKSY 2013
- ATXS 2008
- Country
- BKSY United States
- ATXS United States
- Employees
- BKSY N/A
- ATXS N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- ATXS Health Care
- Exchange
- BKSY Nasdaq
- ATXS Nasdaq
- Market Cap
- BKSY 308.1M
- ATXS 401.2M
- IPO Year
- BKSY N/A
- ATXS 2015
- Fundamental
- Price
- BKSY $9.85
- ATXS $6.19
- Analyst Decision
- BKSY Strong Buy
- ATXS Strong Buy
- Analyst Count
- BKSY 5
- ATXS 6
- Target Price
- BKSY $21.80
- ATXS $25.67
- AVG Volume (30 Days)
- BKSY 2.0M
- ATXS 226.5K
- Earning Date
- BKSY 03-06-2025
- ATXS 03-14-2025
- Dividend Yield
- BKSY N/A
- ATXS N/A
- EPS Growth
- BKSY N/A
- ATXS N/A
- EPS
- BKSY N/A
- ATXS N/A
- Revenue
- BKSY $102,093,000.00
- ATXS N/A
- Revenue This Year
- BKSY $33.53
- ATXS N/A
- Revenue Next Year
- BKSY $33.06
- ATXS N/A
- P/E Ratio
- BKSY N/A
- ATXS N/A
- Revenue Growth
- BKSY 8.04
- ATXS N/A
- 52 Week Low
- BKSY $3.86
- ATXS $5.84
- 52 Week High
- BKSY $21.92
- ATXS $16.90
- Technical
- Relative Strength Index (RSI)
- BKSY 32.42
- ATXS 32.55
- Support Level
- BKSY $11.91
- ATXS $5.84
- Resistance Level
- BKSY $13.55
- ATXS $6.88
- Average True Range (ATR)
- BKSY 1.78
- ATXS 0.33
- MACD
- BKSY -0.90
- ATXS 0.02
- Stochastic Oscillator
- BKSY 2.82
- ATXS 23.97
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.